FLPIM
TRVI icon

F.L. Putnam Investment Management’s Trevi Therapeutics TRVI Stock Holding History

F.L. Putnam Investment Management’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Sell
1,038,057
-25,244
-2% -$367K 0.23% 83
2026
Q1 		$12.7M Buy
1,063,301
+9,874
+0.9% +$111K 0.19% 106
2025
Q4 		$13.2M Buy
1,053,427
+5,325
+0.5% +$61.5K 0.19% 95
2025
Q3 		$9.59M Buy
1,048,102
+961,150
+1,105% +$7.21M 0.14% 123
2025
Q2 		$476K Buy
+86,952
New +$541K 0.01% 424

Other funds holding TRVI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

F.L. Putnam Investment Management's TRVI Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its Trevi Therapeutics (TRVI) stake by 2.4% in Q2 2026, selling an estimated $367K and leaving 1,038,057 shares worth $19.4M. The position accounts for 0.23% of the portfolio, ranked #83.

F.L. Putnam Investment Management first reported a position in TRVI in Q2 2025 and has held it in 5 quarters since. 69 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • F.L. Putnam Investment Management held 1,038,057 shares of Trevi Therapeutics worth $19.4M as of Q2 2026.
  • F.L. Putnam Investment Management sold 25,244 Trevi Therapeutics shares in Q2 2026, an estimated $367K.
  • Trevi Therapeutics made up 0.23% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #83 holding.
  • F.L. Putnam Investment Management first reported a position in Trevi Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 69 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.